242 related articles for article (PubMed ID: 31209056)
21. Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway.
Liu S; Huang S; Wu X; Feng Y; Shen Y; Zhao QS; Leng Y
Mol Metab; 2020 Nov; 41():101045. PubMed ID: 32599076
[TBL] [Abstract][Full Text] [Related]
22. DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling.
Li H; Li J; Zhang X; Feng C; Fan C; Yang X; Zhang R; Zhu F; Zhou Y; Xu Y; Liu H; Tang W
Biochem Pharmacol; 2020 Jul; 177():113958. PubMed ID: 32251674
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase A-dependent activation of PDE4 (cAMP-specific cyclic nucleotide phosphodiesterase) in cultured bovine vascular smooth muscle cells.
Ekholm D; Belfrage P; Manganiello V; Degerman E
Biochim Biophys Acta; 1997 Mar; 1356(1):64-70. PubMed ID: 9099992
[TBL] [Abstract][Full Text] [Related]
24. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
Delgado M; Fernández-Alfonso MS; Fuentes A
Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
[TBL] [Abstract][Full Text] [Related]
25. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.
Houslay MD; Adams DR
Biochem J; 2003 Feb; 370(Pt 1):1-18. PubMed ID: 12444918
[TBL] [Abstract][Full Text] [Related]
26. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
27. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
Chang YH; Conti M; Lee YC; Lai HL; Ching YH; Chern Y
J Neurochem; 1997 Sep; 69(3):1300-9. PubMed ID: 9282956
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation.
MacKenzie KF; Wallace DA; Hill EV; Anthony DF; Henderson DJ; Houslay DM; Arthur JS; Baillie GS; Houslay MD
Biochem J; 2011 May; 435(3):755-69. PubMed ID: 21323643
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
[TBL] [Abstract][Full Text] [Related]
30. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.
Yang JX; Hsieh KC; Chen YL; Lee CK; Conti M; Chuang TH; Wu CP; Jin SC
Sci Rep; 2017 Apr; 7():46165. PubMed ID: 28383060
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP and glycogen synthase kinase 3 form a regulatory loop in spermatozoa.
Dey S; Goswami S; Eisa A; Bhattacharjee R; Brothag C; Kline D; Vijayaraghavan S
J Cell Physiol; 2018 Sep; 233(9):7239-7252. PubMed ID: 29574946
[TBL] [Abstract][Full Text] [Related]
33. Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells.
Naro F; Sette C; Vicini E; De Arcangelis V; Grange M; Conti M; Lagarde M; Molinaro M; Adamo S; Némoz G
Mol Biol Cell; 1999 Dec; 10(12):4355-67. PubMed ID: 10588663
[TBL] [Abstract][Full Text] [Related]
34. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.
Pinto CS; Raman A; Reif GA; Magenheimer BS; White C; Calvet JP; Wallace DP
J Am Soc Nephrol; 2016 Apr; 27(4):1124-34. PubMed ID: 26289612
[TBL] [Abstract][Full Text] [Related]
36. cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm for understanding the unique non-redundant roles that PDE4 isoforms play in shaping compartmentalized cAMP cell signalling.
Lynch MJ; Baillie GS; Houslay MD
Biochem Soc Trans; 2007 Nov; 35(Pt 5):938-41. PubMed ID: 17956250
[TBL] [Abstract][Full Text] [Related]
37. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
Terry R; Cheung YF; Praestegaard M; Baillie GS; Huston E; Gall I; Adams DR; Houslay MD
Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709
[TBL] [Abstract][Full Text] [Related]
38. Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein function.
Murdoch H; Vadrevu S; Prinz A; Dunlop AJ; Klussmann E; Bolger GB; Norman JC; Houslay MD
J Cell Sci; 2011 Jul; 124(Pt 13):2253-66. PubMed ID: 21652625
[TBL] [Abstract][Full Text] [Related]
39. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
Tilley DG; Maurice DH
Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
[TBL] [Abstract][Full Text] [Related]
40. Conserved expression and functions of PDE4 in rodent and human heart.
Richter W; Xie M; Scheitrum C; Krall J; Movsesian MA; Conti M
Basic Res Cardiol; 2011 Mar; 106(2):249-62. PubMed ID: 21161247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
